Junji Saruwatari
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Junji Saruwatari is an Associate Professor at Kumamoto University in Japan. His research areas focus on the disruption of circadian rhythms in infants and its implications for autism spectrum disorder, the protective effects of carbon monoxide-loaded red blood cells in acute kidney injury, and the analysis of serum fatty acid composition in relation to metabolic dysfunction. His recent publications reflect a commitment to advancing knowledge in these critical areas of health and disease.
Articles (9)
Year:
2026
Selective serotonin reuptake inhibitors (SSRIs) are widely used in depression treatment. However, the relationship between treatment efficacy and plasma concentrations remains unclear. We assessed whether the anti‐depressive response can be predicted based on the pharmacokinetic (PK) data of paroxetine, a frequently used SSRI. During treatment, we measured the plasma paroxetine concentrations in 179 paroxetine‐treated patients with major depressive disorder. Of these patients, 50 patients had received a pre‐treatment personality assessment using the Temperament and Character Inventory at baseline, and their depression severity was assessed using the Montgomery‐Asberg Depression Rating Scale (MADRS) at baseline and 1, 2, 4, and 6 weeks after treatment initiation. We conducted population PK modeling followed by a population PK‐pharmacodynamic (popPK/PD) model to analyze the enhancement in depression severity until 6 weeks of paroxetine treatment using nonlinear mixed‐effects modeling. Additionally, we developed machine learning models to predict the likelihood of remission after 6 weeks. The contribution of each feature to the prediction was explained using SHapley Additive exPlanations (SHAP) values. The area under the plasma paroxetine concentration‐time curve during the first week (AUC 0–1week ) and MADRS score after 1 week of treatment (MADRS W1 ) were incorporated into the popPK/PD model. The SHAP values indicated that the AUC 0–1week and MADRS W1 were the significant predictors of remission. Our results indicate that therapeutic responsiveness to paroxetine can be anticipated from its cumulative exposure, highlighting the clinical relevance of assessing SSRI blood concentrations.
Year:
2025
We investigated whether the abnormal rhythms in infants are related to the future development of autism spectrum disorder (ASD), using a questionnaire from September to October 2016. The parents of 160 children with ASD (male, n = 123; female, n = 37) were recruited from two hospitals in K and H cities, and as a control group, 145 children (male, n = 75; female, n = 70) were recruited from four nursery schools in T city. The associations between ASD and bedtime and waking time on weekdays and weekends in infancy ( 60 min); (3) sleep beginning after 22:00; (4) a wake-up time after 08:00; and (5) frequent (>3 times) and long-term awakening periods (>60 min). The misalignment and/or shift of the circadian rhythm in infants may be one of the precursors and/or risk factors for the future development of ASD.
Year:
2024
Aim Yokukansan is one of the most frequently used herbal medicines that can improve the behavioral and psychological symptoms of dementia. In this exploratory study, we investigated whether yokukansan affects the steady‐state blood concentrations of donepezil, risperidone, and the major metabolites of both drugs in a real‐world clinical setting. Methods A non‐randomized, open‐label, single‐arm study examining drug–drug interactions was conducted. Fifteen dementia patients taking donepezil for at least 4 weeks and eight schizophrenia patients taking risperidone for at least 2 weeks were orally administered 2.5 g of yokukansan three times a day before or between meals, and blood samples were collected before and 8 weeks after starting co‐treatment with yokukansan. Plasma concentrations of donepezil, risperidone, and each metabolite were measured using high‐performance liquid chromatography–tandem mass spectrometry and compared before and after the 8‐week administration of yokukansan. Results The plasma concentrations of donepezil and its metabolites (6‐ O ‐desmethyl‐donepezil, 5‐ O ‐desmethyl‐donepezil, and donepezil‐ N ‐oxide), risperidone, and its metabolite paliperidone did not differ before and after the 8‐week treatment with yokukansan. Conclusions The findings of this study show that the concomitant use of yokukansan may have little clinical impact on the steady‐state blood levels of donepezil and risperidone in patients with dementia or schizophrenia.
Year:
2024
The saturation of self-care products in the market is coupled with inadequate information on their safe usage. In Japan, although foods with function claims (FFC) are prevalent, their labelling falls short in quality and effectiveness as health information, impeding consumer comprehension and proper utilization. Hence, it is imperative to establish a system that assesses the efficacy of labelling information from both provider and user perspectives. From providers’ or healthcare professionals’ perspective, we already developed a Communication Index to assess FFC labelling, which we utilized to evaluate five FFC products. Those products achieved a proficiency level of approximately 70%, falling below the acceptance criteria. Particularly, challenges were identified in understanding some of the terms and locating important information on the labels. In this study, we conducted user-testing from the user perspective for five same FFC labels to evaluate them using semi-structured interviews with 50 participants of diverse ages and sexes. A passing criterion for comprehension was set as ≥90% correct responses to all questions. Of the five FFC products, one passed the user-testing criterion with a 2-min response time; however, none passed the 1-min response time test. The proportions of correct answers were notably low for questions on diet and allergies (each 50-90%), concomitant medications (50-100%), storage (30-100%), and handling (30-100%). Participants’ comments revealed a lack of familiarity with FFC, highlighting that the terms and text in the labelling were confusing and overly technical. User-testing provides valuable insights for improving FFC labelling, thereby ensuring safe and appropriate use by aligning with consumers’ understanding and perceptions. We assessed FFC label information from both the provider and user perspectives, but neither yielded satisfactory results. Consequently, the implementation of an integrated system capable of evaluating FCC labels as health information material from both perspectives would be necessary.
Year:
2024
We investigated if the abnormal sleep-wake rhythms in infants are related to the future development of autism spectrum disorder (ASD), using questionnaire from September to October 2016. The parents of a total 160 children with ASD (male, n=123; female, n=37) recruited from the two hospitals in K and H cities and as a control group, 145 children (male, n=75; female, n=70) recruited from four nursery schools in T city. Fisher’s exact test was used for the comparison of categorical variables. The associations of bedtime and waking time on weekdays and holidays in infancy, at 1-3≦ (1-3) years of age and at 3-5 ≦ (3-5)years of age with the prevalence of ASD were analyzed using a multivariable logistic regression analysis. Especially by 3 years of age, the following factors were associated with an increased risk of developing ASD in the future: 1) short sleep (<8h), 2) long time to fall asleep (>60min), 3) sleep onset time after 22:00h, 4) wake-up time after 07:00h and/or 08:00h on weekdays and holidays, respectively, 5) frequent (>3 times) and long-term awakening (>60min). Misalignment and/or shift of the sleep-wake circadian rhythm in infant may be one of the precursors and/or risk factor to the future development of ASD.
Year:
2024
Year:
2023
Circulating fatty acid composition is assumed to play an important role in metabolic dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to investigate the association between the overall balance of serum fatty acid composition and MAFLD prevalence. This cross-sectional study involved 400 Japanese individuals recruited from a health-screening program. We measured fatty acids in serum lipids using gas chromatography–mass spectrometry. The serum fatty acid composition balance was evaluated using fuzzy c-means clustering, which assigns individual data points to multiple clusters and calculates the percentage of data points belonging to multiple clusters, and serum fatty acid mass%. The participants were classified into four characteristic subclasses (i.e., Clusters 1, 2, 3, and 4), and the specific serum fatty acid composition balance (i.e., Cluster 4) was associated with a higher MAFLD prevalence. We suggest that the fuzzy c-means method can be used to determine the circulating fatty acid composition balance and highlight the importance of focusing on this balance when examining the relationship between MAFLD and serum fatty acids.
Year:
2023
Aims. This study is aimed at clarifying the relationship between visit-to-visit variability of glycated hemoglobin (HbA1c) and the risk of diabetic kidney disease (DKD) and to identifying the most useful index of visit-to-visit variability of HbA1c. Methods. This clinic-based retrospective longitudinal study included 699 Japanese type 2 diabetes mellitus patients. Visit-to-visit variability of HbA1c was calculated as the internal standard deviation of HbA1c (HbA1c-SD), the coefficient of variation of HbA1c (HbA1c-CV), the HbA1c change score (HbA1c-HVS), and the area under the HbA1c curve (HbA1c-AUC) with 3-year serial HbA1c measurement data, and the associations between these indices and the development/progression of DKD were examined. Results. Cox proportional hazards models showed that the HbA1c-SD and HbA1c-AUC were associated with the incidence of microalbuminuria, independently of the HbA1c level. These results were verified and replicated in propensity score (PS) matching and bootstrap analyses. Moreover, the HbA1c-SD and HbA1c-AUC were also associated with oxidized human serum albumin (HSA), an oxidative stress marker. Conclusions. Visit-to-visit variability of HbA1c was an independent risk factor of microalbuminuria in association with oxidative stress among type 2 diabetes mellitus patients. HbA1c-AUC, a novel index of HbA1c variability, may be a potent prognostic indicator in predicting the risk of microalbuminuria.
Year:
2022
Collaborators (9)
Ken Yamamoto
Showa Pharmaceutical University
Norio Yasui‐Furukori
Associate Professor
Dokkyo Medical University
Kentaro Oniki
Kumamoto University
Ayami Morita
Assistant professor
Kumamoto University
Hirofumi Jono
Associate professor
Kumamoto University
Hiroki Itoh
Professor
Oita University Hospital
Hiroshi Watanabe
Professor
Kumamoto University
Hiromi Sakai
Professor
Nara Medical University
Daisuke Kadowaki
Sojo University
Make your next move.
Prepare your application
Review drafts before you send them.